ConductScience.org, home

Paper32150405

CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?

Diab S and 2 others. J Med Chem, 2020. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success? Papers, record 32150405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32150405

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
PubMed
Journal
J Med Chem
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
3.09
iCite
Revised in PubMed
2022-12-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Diab SSarahhttps://orcid.org/0000-0002-6705-317X
2Yu MMingfeng
3Wang SShudonghttps://orcid.org/0000-0001-6225-5525

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cyclin-Dependent KinasesMajor topic
NeoplasmsMajor topic
Protein Kinase InhibitorsMajor topic
Animals
Apoptosis
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Humans
Cyclin-Dependent Kinase-Activating Kinase

Source PubMed

Download CSV of topics

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
42635915Targeting CDK7 to overcome hypomethylating agent resistance in acute myeloid leukemia.Blood Res2026https://conductscience.org/library/papers/42635915PubMed
42209292Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors.J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/42209292PubMed
41575477Palladium-catalyzed Suzuki-Miyaura and Buchwald-Hartwig cross-coupling reactions towards the synthesis of pharmacologically potent pyrimidine-based molecules.Mol Divers2026https://conductscience.org/library/papers/41575477PubMed
41428738CDK7-CDK11 axis in spliceosome regulation and pre-mRNA splicing.Nucleic Acids Res2025https://conductscience.org/library/papers/41428738PubMed
41188290Transcriptome-conditioned molecule generation via gene interaction-aware fragment modeling with a GPT-based architecture.Sci Rep2025https://conductscience.org/library/papers/41188290PubMed
41158223Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative review.Transl Cancer Res2025https://conductscience.org/library/papers/41158223PubMed
41092317Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.J Natl Cancer Inst2026https://conductscience.org/library/papers/41092317PubMed
40949156Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets.Front Pharmacol2025https://conductscience.org/library/papers/40949156PubMed
40853714Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models.ChemMedChem2025https://conductscience.org/library/papers/40853714PubMed
39588561Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.Mol Cancer Ther2025https://conductscience.org/library/papers/39588561PubMed
39414519Emerging roles of cyclin-dependent kinase 7 in health and diseases.Trends Mol Med2025https://conductscience.org/library/papers/39414519PubMed
39140066Design, Synthesis, and Biological Evaluation of 2,4-Diaminopyrimidine Derivatives as Potent CDK7 Inhibitors.ACS Med Chem Lett2024https://conductscience.org/library/papers/39140066PubMed
39023263Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/39023263PubMed
39004018Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7).Eur J Med Chem2024https://conductscience.org/library/papers/39004018PubMed
38983782Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside.EXCLI J2024https://conductscience.org/library/papers/38983782PubMed
38892310Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation.Int J Mol Sci2024https://conductscience.org/library/papers/38892310PubMed
38872861Cancer research in Lebanon: Scope of the most recent publications of an academic institution (Review).Oncol Lett2024https://conductscience.org/library/papers/38872861PubMed
38845825Exploring isoindolin-1-ones as potential CDK7 inhibitors using cheminformatic tools.In Silico Pharmacol2024https://conductscience.org/library/papers/38845825PubMed
38748374Computer-aided analysis of radiological images for cancer diagnosis: performance analysis on benchmark datasets, challenges, and directions.EJNMMI Rep2024https://conductscience.org/library/papers/38748374PubMed
38355840Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer.Br J Cancer2024https://conductscience.org/library/papers/38355840PubMed

See all 40 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CDK71022PubTator's text mininghttps://conductscience.org/library/genes/1022

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32150405

GET https://conductscience.org/api/papers/v1/32150405/cited_by?page=2